A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors
Clinical trial NCT07537881 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07537881
- Sponsor
- RemeGen Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2029-12-30
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.